These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9723447)
1. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation. Xu M; Pirenne J; Antoniou S; Gunson B; D'Silva M; McMaster P Transplant Proc; 1998 Aug; 30(5):2221-2. PubMed ID: 9723447 [No Abstract] [Full Text] [Related]
2. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation. Xu M; Antoniou EA; Afford SC; Suzuki S; Pirenne J; McMaster P; D'Silva M Transplant Proc; 1997 Nov; 29(7):2964-6. PubMed ID: 9365631 [No Abstract] [Full Text] [Related]
3. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models. Hoshino Y; Yanagawa Y; Ohtsuki M; Nakayama S; Hashimoto T; Chiba K Transplant Proc; 1999; 31(1-2):1224-6. PubMed ID: 10083547 [No Abstract] [Full Text] [Related]
4. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. Yamashita K; Nomura M; Omura T; Takehara M; Suzuki T; Shimamura T; Kishida A; Furukawa H; Murakami M; Uede T; Todo S Transplant Proc; 1999; 31(1-2):1178-9. PubMed ID: 10083526 [No Abstract] [Full Text] [Related]
5. Rescuing acute rejection of rat cardiac allografts with FTY720. Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868 [No Abstract] [Full Text] [Related]
6. Combination effect of tacrolimus and FTY720 in liver transplantation in rats. Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290 [No Abstract] [Full Text] [Related]
7. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model. Matsumoto Y; Hof RP Transplant Proc; 2002 Nov; 34(7):2891-2. PubMed ID: 12431647 [No Abstract] [Full Text] [Related]
8. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation. Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M Transplant Proc; 1998 Jun; 30(4):1042-3. PubMed ID: 9636420 [No Abstract] [Full Text] [Related]
9. FTY720 prevents chronic rejection of rat heterotopic cardiac allografts. Chueh SC; Chen JR; Chen J; Lai MK Transplant Proc; 2001; 33(1-2):542-3. PubMed ID: 11266948 [No Abstract] [Full Text] [Related]
10. Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation. Ohba M; Li XK; Kita Y; Tamura A; Enosawa S; Sasakuri S; Ogoshi S; Amemiya H; Suzuki S Transplant Proc; 2000 Nov; 32(7):2024-5. PubMed ID: 11120049 [No Abstract] [Full Text] [Related]
11. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Nikolova Z; Hof A; Baumlin Y; Hof RP Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317 [TBL] [Abstract][Full Text] [Related]
12. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Nikolova Z; Hof A; Baumlin Y; Hof RP Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070 [TBL] [Abstract][Full Text] [Related]
13. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival. Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445 [No Abstract] [Full Text] [Related]
14. Prolongation of concordant xenograft survival by a newly developed drug, FTY720. Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306 [No Abstract] [Full Text] [Related]
15. Prolongation of concordant xenograft survival by treatment with FTY720. Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334 [No Abstract] [Full Text] [Related]
16. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
17. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
18. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation. Xu M; Pirenne J; Antoniou EA; Afford SC; D'Silva M; McMaster P Transpl Int; 1998; 11(4):288-94. PubMed ID: 9704394 [TBL] [Abstract][Full Text] [Related]
19. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting. Kita Y; Li XK; Funeshima N; Enosawa S; Tamura A; Hayashi S; Suzuki K; Kazui T; Amemiya H; Suzuki S Transplant Proc; 1999 Nov; 31(7):2787-8. PubMed ID: 10578291 [No Abstract] [Full Text] [Related]
20. Tolerance induction with FTY720 and donor-specific blood transfusion: discrepancy between heart transplantation and intestinal transplantation. Koshiba T; Ji P; Tanaka K; McMaster P; Van Damme B; Waer M; Pirenne J Transplant Proc; 2000 Sep; 32(6):1255-7. PubMed ID: 10995936 [No Abstract] [Full Text] [Related] [Next] [New Search]